Virax Biolabs Group Ltd - Ordinary Shares - Class A - VRAX - stock price prediction, stock price target, analyst ratings from 1 analyst

Virax Biolabs Group Ltd - Ordinary Shares - Class A has a share price target of US$ 3, revenue growth forecast of 300.0%, and profit growth estimate of 2.3% for FY26, based on top 1 analyst call.